251 related articles for article (PubMed ID: 23880147)
1. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France).
Vanier A; Leux C; Allioux C; Billon-Delacour S; Lombrail P; Molinié F
Cancer Epidemiol; 2013 Oct; 37(5):683-7. PubMed ID: 23880147
[TBL] [Abstract][Full Text] [Related]
2. [Incidence and prognostic factors of breast cancer diagnosed within and outside of the organised screening program in the department of Loire-Atlantique (1991-2002)].
Molinié F; Billon-Delacour S; Allioux C; Blais S; Bercelli P; Lombrail P
Rev Epidemiol Sante Publique; 2008 Feb; 56(1):41-9. PubMed ID: 18295424
[TBL] [Abstract][Full Text] [Related]
3. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening.
Hofvind S; Skaane P
Rofo; 2012 May; 184(5):437-42. PubMed ID: 22426937
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic mode and tumor staging of breast cancers in the setting of opportunistic screenings].
Graf O; Obermayer M; Scheurecker A; Hopf G; Kramer J; Frühwald F
Rofo; 2006 Feb; 178(2):221-6. PubMed ID: 16435254
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey.
Duport N
Rev Epidemiol Sante Publique; 2012 Dec; 60(6):421-30. PubMed ID: 23146369
[TBL] [Abstract][Full Text] [Related]
6. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
7. Population-based study of breast cancer screening in Côte d'Or (France): clinical implications and factors affecting screening round adequacy.
Ouedraogo S; Dabakuyo TS; Gentil J; Poillot ML; Dancourt V; Arveux P
Eur J Cancer Prev; 2011 Nov; 20(6):462-74. PubMed ID: 22025137
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
[TBL] [Abstract][Full Text] [Related]
9. Trends in invasive breast cancer incidence among French women not exposed to organized mammography screening: an age-period-cohort analysis.
Viel JF; Rymzhanova R; Fournier E; Danzon A
Cancer Epidemiol; 2011 Dec; 35(6):521-5. PubMed ID: 21621498
[TBL] [Abstract][Full Text] [Related]
10. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
11. [Screening for breast cancer: worries about its effectiveness].
Autier P
Rev Prat; 2013 Dec; 63(10):1369-77. PubMed ID: 24579331
[TBL] [Abstract][Full Text] [Related]
12. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
13. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study.
Musolino A; Michiara M; Conti GM; Boggiani D; Zatelli M; Palleschi D; Bella MA; Sgargi P; Di Blasio B; Ardizzoni A
J Clin Oncol; 2012 Jul; 30(19):2362-8. PubMed ID: 22585698
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer incidence: Decreasing trend in large tumours in women aged 50-74.
Molinié F; Delacour-Billon S; Tretarre B; Delafosse P; Seradour B; Colonna M
J Med Screen; 2017 Dec; 24(4):189-194. PubMed ID: 27810986
[TBL] [Abstract][Full Text] [Related]
16. Performance of systematic and non-systematic ('opportunistic') screening mammography: a comparative study from Denmark.
Bihrmann K; Jensen A; Olsen AH; Njor S; Schwartz W; Vejborg I; Lynge E
J Med Screen; 2008; 15(1):23-6. PubMed ID: 18416951
[TBL] [Abstract][Full Text] [Related]
17. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
[TBL] [Abstract][Full Text] [Related]
18. Opportunistic breast cancer early detection in Tyrol, Austria 1996-2004. Is a mammography-screening program necessary?
Frede TE
Eur J Radiol; 2005 Jul; 55(1):130-8. PubMed ID: 15925467
[TBL] [Abstract][Full Text] [Related]
19. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
[TBL] [Abstract][Full Text] [Related]
20. The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value?
Biesheuvel C; Czene K; Orgeás CC; Hall P
Cancer Epidemiol; 2011 Dec; 35(6):545-50. PubMed ID: 21470933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
